Halaven

Halaven is a prescription medication used to treat breast and soft tissue cancers. Halaven belongs to a group of drugs called microtubule inhibitors, which stop the growth and spread of cancer cells.

This medication comes in an injectable form and is given into the vein (intravenously) by a healthcare provider on days 1 and 8 of a 21-day cycle.

Common side effects include weakness, tiredness, hair loss, and nausea.

Breast Cancer Female [1] Cancer [2]

Reviewed by:

Anyssa Garza, PharmD [3]

Citation:

"Halaven", DailyMed: Current Medication Information; U.S. National Library of Medicine [4] FDA approves first drug to show survival benefit in liposarcoma. FDA News Release. 2016 [5]

http://www.rxwiki.com/halaven [6]

Eribulin [7]

Rx Company Link:

Eisai, Inc [8]

RxNorm ATC Ref:

OTHER ANTINEOPLASTIC AGENTS [9]

Contributor:

Anyssa Garza, PharmD [3] Teresa Brucker, Pharm.D [10] Beth Bolt, RPh [11] Eric Ho, Pharm.D [12] Jennifer Gershman, PharmD, CPh [13]

Photo:

published_note:

RX Label Type:

Long Title:

Halaven treats breast and soft tissue cancers. Your doctor will check your blood cell counts before you receive each dose of Halaven.

Black Box Warning Image:

Uses Show:

Side Effects Show:

Side Effects Image:

Drug Interactions Show:

Drug Precautions Show:

Food Interactions Show:

Inform MD Show:

Inform MD Image:

Pregnant Show:

Lactation Show:

Drug Usage Show:

Drug Dosage Show:

Overdose Show:

Forms of Medication Show:

Other Requirements Show:

Brand Names Show:

Drug Class Show: